Gland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Audited Financial Results For The Quarter And Financial Year Ended 31.03.2024 And To Consider And Recommend The Payment Of Final Dividend For FY 2023-24
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 ,inter alia, to consider and approve Audited Financial Results for the quarter and financial year ended 31.03.2024 and to consider and recommend the payment of Final Dividend for FY 2023-2409-05-2024